Emerging Triglyceride-Rich Lipoprotein Targeted Therapies: An Unmet Need in Cardiometabolic Disease.

Pharmaceutics · 2025 · PMC12472825 · PMID 41012446

Europe PMC DOI

hedged sentence

0.0060

closest p · 0.1× alpha

0.0060

boldest claim

The sentences

a significant trendp = 0.006actually significant

Hazard ratios (95% confidence intervals) across increasing tertiles were 1.0 (reference), 1.44 (0.90–2.29), and 1.98 (1.21–3.25), with a significant trend ( p = 0.006).

also in 3,203 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.